Outbreak of Pseudomonas fluorescens bacteremia among oncology patients

Journal of Clinical Microbiology

Volumn 36, Issue 10, 1998, Pages 2914-2917

  Hsueh, Po Ren ^a   Teng, Lee Jene ^b   Pan, Hui Ju ^a   Chen, Yu Chi ^a   Sun, Chun Chuan ^a   Ho, Shen Wu ^b   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOPERAZONE; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; DNA; IMIPENEM; MINOCYCLINE; NETILMICIN; OFLOXACIN; PIPERACILLIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CANCER PATIENT; CASE REPORT; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; RALSTONIA PICKETTII;

EID: 0031656719     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.10.2914-2917.1998     Document Type: Article

References (15)

1. Blazevic, D. J., M. H. Koepcke, and J. M. Matsen. 1973. Incidence and identification of Pseudomonas fluorescens and Pseudomonas putida in the clinical laboratory. Appl. Microbiol. 25:107-110.
2. Gilligan, P. H. 1995. Pseudomonas and Burkholderia, p. 509-519. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
3. Hsueh, P.-R., L.-J. Teng, S.-W. Ho, W.-C. Hsieh, and K.-T. Luh. 1996. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J. Clin. Microbiol. 34:1908-1913.
4. Hsueh, P. R., L. J. Teng, P. I. Lee, P. C. Yang, L. M. Huang, S. C. Chang, C. Y. Lee, and K. T. Luh. 1997. Outbreak of scarlet fever at a hospital day care centre: analysis of strain relatedness with phenotypic and genotypic characteristics. J. Hosp. Infect. 36:191-200.
5. Jones, R. N., K. E. Aldridge, S. D. Allen, A. L. Barry, P. C. Fuchs, E. H. Gerlach, and M. A. Pfaller. 1989. Multicenter in vitro evaluation of SM-7338, a new carbapenem. Antimicrob. Agents Chemother. 33:562-565.
6. Lazarus, H. M., M. Magalhaes-Silverman, R. M. Fox, R. J. Creger, and M. Jacobs. 1991. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Bone Marrow Transplant. 7:241-246.
7. Murray, A. E., C. A. Bartzokas, A. J. N. Shepherd, and F. M. Roberts. 1987. Blood transfusion associated Pseudomonas fluorescens septicaemia: is this an increasing problem? J. Hosp. Infect. 9:243-248.
8. National Committee for Clinical Laboratory Standards. 1998. Performance standard for antimicrobial susceptibility testing: eighth informational supplement. M100-S8. National Committee for Clinical Laboratory Standards, Villanova. Pa.
9. Osterhout, G. J., V. H. Shull, and J. D. Dick. 1991. Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system. J. Clin. Microbiol. 29:1822-1830.
10. Pickett, M. J., J. R. Greenwood, and S. M. Harvey. 1991. Tests for detecting degradation of gelatin: comparison of five methods. J. Clin. Microbiol. 29: 2322-2325.
11. Puckett, A., G. Davison, C. C. Entwistle, and J. A. J. Barbara. 1992. Post-transfusion septicemia 1980-1989: importance of donor arm cleansing. J. Clin. Pathol. 45:155-157.
12. Scott, J., F. E. Boulton, J. R. W. Govan, R. S. Miles, D. B. L. McClelland, and C. V. Prowse. 1988. A fatal transfusion reaction associated with contamination with Pseudomonas fluorescens. Vox. Sang. 54:201-204.
13. Simor, A. E., J. Ricci, A. Lau, R. M. Bannatyne, and L. Ford-Jones. 1985. Pseudobacteremia due to Pseudomonas fluorescens. Pediatr. Infect. Dis. 4: 508-512.
14. Veys, A., W. E. Callewaert, E. Waelkens, and K. V. D. Abbeele. 1989. Application of gas-liquid chromatography to the routine identification of nonfermentative gram-negative bacteria in clinical specimens. J. Clin. Microbiol. 27:1538-1542.
15. Watanabe, N.-A., K. Katsu, M. Moriyama, and K. Kitoh. 1988. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity. Antimicrob. Agents Chemother. 32:693-701.